CGN Advisors LLC raised its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 15.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 31,585 shares of the biopharmaceutical company’s stock after buying an additional 4,187 shares during […]
Caisse DE Depot ET Placement DU Quebec increased its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 3.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,130,699 shares of the biopharmaceutical company’s stock after buying an […]
CIBC Asset Management Inc trimmed its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 4.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 429,710 shares of the biopharmaceutical company’s stock after selling 22,373 shares during the […]
Ethic Inc. increased its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 48.7% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 95,039 shares of the biopharmaceutical company’s stock after acquiring an additional 31,117 shares during the period. Ethic Inc.’s holdings in Gilead […]
Vise Technologies Inc. grew its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 20.2% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 20,601 shares of the biopharmaceutical company’s stock after buying an additional 3,455 shares during the quarter. Vise Technologies Inc.’s holdings in Gilead Sciences were worth $1,709,000 […]